New Zealand markets closed

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
228.57-10.93 (-4.56%)
At close: 04:00PM EST
228.54 -0.03 (-0.01%)
After hours: 04:46PM EST
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Assets
Current assets
Cash
Cash and cash equivalents
241,214
228,424
238,014
195,442
Other short-term investments
1,063
1,024
941
885
Total cash
242,277
229,448
238,955
196,327
Net receivables
489,452
489,042
395,740
370,131
Inventory
199,146
185,695
160,660
127,892
Other current assets
97,311
72,560
300
300
Total current assets
1,274,095
1,201,131
1,021,325
897,836
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,686,989
2,388,571
2,161,783
1,807,012
Accumulated depreciation
-1,102,980
-1,085,993
-977,570
-874,135
Net property, plant and equipment
1,584,009
1,302,578
1,184,213
932,877
Equity and other investments
201,352
221,804
122,979
88,591
Goodwill
2,711,881
1,809,168
1,540,565
1,247,133
Intangible assets
1,061,192
787,599
689,413
610,888
Other long-term assets
93,265
75,422
89,636
55,168
Total non-current assets
5,750,197
4,289,700
3,671,465
2,958,043
Total assets
7,024,292
5,490,831
4,692,790
3,855,879
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
101
47,196
35,548
31,416
Accounts payable
198,130
122,475
111,498
66,250
Taxes payable
26,161
24,884
26,066
24,120
Accrued liabilities
228,797
149,820
139,118
106,925
Deferred revenues
279,215
250,186
204,885
183,384
Other current liabilities
18,701
10,675
11,095
8,915
Total current liabilities
1,033,185
839,751
710,181
558,222
Non-current liabilities
Long-term debt
2,636,341
1,903,542
1,822,136
1,636,598
Deferred tax liabilities
239,720
217,031
167,283
143,635
Deferred revenues
20,578
19,475
20,983
34,420
Other long-term liabilities
74,280
62,726
29,051
31,880
Total non-current liabilities
3,399,115
2,507,412
2,316,134
1,959,354
Total liabilities
4,432,300
3,347,163
3,026,315
2,517,576
Stockholders' equity
Common stock
505
498
489
482
Retained earnings
980,751
625,414
280,329
42,096
Accumulated other comprehensive income
-164,740
-138,874
-178,019
-172,703
Total stockholders' equity
2,534,820
2,114,602
1,634,584
1,317,332
Total liabilities and stockholders' equity
7,024,292
5,490,831
4,692,790
3,855,879